Additional file 4: Table S1. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial
journal contributionposted on 19.08.2015 by Dave Singh, Sally Worsley, Chang-Qing Zhu, Liz Hardaker, Alison Church
Any type of content formally published in an academic journal, usually following a peer-review process.
Proportion of patients achieving an increase FEV1 ≥ 0.100 L above baseline at various times post-dose on Day 1 (ITT population; post hoc analyses). (DOC 38 kb)